Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02878707 : The Neuroprotective Effects of Dexmedetomidine During Brain Surgery
PhaseN/A
AgesMin: 20 Years Max: 75 Years
Eligibility
Inclusion Criteria:

- Patients undergoing elective craniotomy for supratentorial brain tumor resection or
cerebral vascular surgery

- age between 20 to 75 yr

Exclusion Criteria:

- Evidence of infectious conditions, such as fever, elevated white blood cell or
C-reactive protein

- Impaired liver function, eg. AST or ALT >100; liver cirrhosis > Child B class

- Impaired renal function, cGFR< 60 ml/min/1.73 m2

- Cardiac dysfunction, such as heart failure > NYHA class II, coronary arterial disease
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02878707      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740